Diabetes News Roundup: New Thoughts on Standard Thinking

June 27, 2017

Find research on diabetes patients that could shift your thinking on home blood glucose monitoring; metformin efficacy in T1DM; and race and A1c.

New research into both T2DM and T1DM includes sudies on: ► Value of routine glucose self-monitoring in T2DM management in patients who do not take insulin ► Impact of metformin in patients with T1DM on weight, LDL-C, and development of atherosclerosis--but what about glycemic control?  ► Accuracy of A1c to estimate average glucose levels in blacks compared with whites.Click through our slide show of brief summaries above. References Type 2 DM Patients May Not Need Routine Home Blood Glucose Monitoring. Young LA, et al. Glucose Self-monitoring in Non–Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings. JAMA Intern Med. Published online June 10, 2017. doi:10.1001/jamainternmed.2017.1233Cardiovascular and Metabolic Effects of Metformin in Type 1 Diabetes. Petrie JR, et al. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial. Lancet Diabetes Endocrinol. Published June 11 2017 DOI: http://dx.doi.org/10.1016/S2213-8587(17)30194-8Racial Differences in Hemoglobin A1c Levels. Bergenstal RM, et al. Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels.  Ann Intern Med. 2017. DOI: 10.7326/M16-2596